Brain age gap estimation (BrainAGE) is a promising imaging-derived biomarker of neurobiological aging and disease risk, yet current approaches rely predominantly on T1-weighted structural MRI (T1w), overlooking functional vascular changes that may precede tissue damage and cognitive decline. Artificial intelligence-generated cerebral blood volume (AICBV) maps, synthesized from non-contrast MRI, offer an alternative to contrast-enhanced perfusion imaging by capturing vascular information relevant to early neurodegeneration. We developed a multimodal BrainAGE framework that integrates brain age predictions using linear regression from two separate 3D VGG-based networks, one model trained on only structural T1w scans and one trained on only AICBV maps generated from a pre-trained 3D patch-based deep learning model. Each model was trained and validated on 2,851 scans from 13 open-source datasets and was evaluated for concordance with mild cognitive impairment (MCI) and Alzheimer's disease (AD) using ADNI subjects (n=1,233). The combined model achieved the most accurate brain age gap for cognitively normal (CN) controls, with a mean absolute error (MAE) of 3.95 years ($R^2$=0.943), outperforming models trained on T1w (MAE=4.10) or AICBV alone (MAE=4.49). Saliency maps revealed complementary modality contributions: T1w emphasized white matter and cortical atrophy, while AICBV highlighted vascular-rich and periventricular regions implicated in hypoperfusion and early cerebrovascular dysfunction, consistent with normal aging. Next, we observed that BrainAGE increased stepwise across diagnostic strata (CN < MCI < AD) and correlated with cognitive impairment (CDRSB r=0.403; MMSE r=-0.310). AICBV-based BrainAGE showed particularly strong separation between stable vs. progressive MCI (p=$1.47 \times 10^{-8}$), suggesting sensitivity to prodromal vascular changes that precede overt atrophy.